C

Clearside Biomedical
D

CLSD

0.43000
USD
-0.02
(-3.59%)
مغلق
حجم التداول
444
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
33,759,437
أصول ذات صلة
C
CRSP
0.853
(1.45%)
59.683 USD
C
CRVS
0.57000
(11.74%)
5.42500 USD
E
EDIT
0.08000
(2.70%)
3.04000 USD
N
NTLA
0.090
(0.83%)
10.995 USD
R
RGNX
-0.24500
(-2.70%)
8.82500 USD
S
SGMO
0.02420
(4.37%)
0.57800 USD
V
VCEL
0.540
(1.51%)
36.300 USD
المزيد
الأخبار المقالات

العنوان: Clearside Biomedical

القطاع: Healthcare
الصناعة: Biotechnology
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.